AbacaRx Announces New Crowdfunding Campaign to Support

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
AbacaRx Announces New Crowdfunding Campaign to Support Online Doctor Service for Medical Marijuana

SAN FRANCISCO, Calif., June 5, 2014 (GLOBE NEWSWIRE) -- via PRWEB - AbacaRx Telemedicine Inc ., the world's first online marijuana consultation and recommendation service, has created a nation-wide service and app allowing people to connect with board-certified physicians from the comfort of their own home and receive a medical assessment to see if they could benefit from medical marijuana.

To fund this progressive app, AbacaRx is announcing its Indiegogo crowdfunding campaign launching June 4th to run for 35 days with a target goal of $100,000.

The campaign will sponsor both the completion of the software and the expansion of the doctor network that is knowledgeable on the therapeutic aspects of medical marijuana.

Despite the use of medical marijuana becoming more mainstream and public opinion growing in favor of tolerance for marijuana, many still feel uncomfortable seeking a local doctor's recommendation for its use.

"We designed the app to offer a safe and secure online platform for those to comfortably seek medical advice, ask questions, and find out if medical marijuana is right for them," says Boris Drubetsky, the COO of AbacaRx.

The crowdfunding campaign will allow people to connect to doctors using their computer, smartphone or tablet with features including high definition and encrypted video for conferences with the doctor, as well as the ability to securely store medical records and access to an online education center.

"There are currently 22 States and D.C. that have legalized medical marijuana and there are four other States with pending legislation. This means there's a significant amount of people out there who could potentially use this service to find out if marijuana could help them," says Roger Proctor, the CEO of AbacaRx.

This campaign will test the level of public interest out there for this new, innovative way to seek medical guidance. Proctor sees this service as taking the first step to delivering healthcare alternatively to people in need.

"Medical Marijuana itself is an alternative medication and AbacaRx is following suit in providing an alternative way to seek medical advice about it. We are confident the public will see our vision and support the development of AbacaRx taking its first step to help people seek treatment responsibly and legally."

About AbacaRx: Founded in October 2013 by CEO Roger Proctor and COO Boris Drubetsky, AbacaRx is the first online telemedicine service dedicated to connecting people to physicians that are educated on Medical Marijuana to get a recommendation. Telemedicine represents a new and innovative way to deliver healthcare and AbacaRx is pioneering a whole new application for its use.

This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2014/06/prweb11916731.htm

AbacaRx Kevin Lowe +1 1-888-909-8647

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 34

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 44

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 41

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 39

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 31

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

KPN Achieves Impressive Growth; Forecast for 2025 Enhanced

Updated Category News Views 271

KPN Achieves Remarkable Growth in Q2 2025 KPN has recently demonstrated a strong performance in the second quarter of 2025, showcasing impressive growth across various segments. The company reported a year-on-year growth of 3.7% in service revenues, a testament to its robust business strategy and market position. Consumer Service Revenue Gains The consumer segment has...

Continue Reading
Socket Mobile's Financial Trends Show Promise for Future Growth

Updated Category News Views 66

Socket Mobile Reports Q3 Financial Results Socket Mobile, Inc. (NASDAQ: SCKT), a prominent name in the field of data capture and delivery solutions, recently disclosed its financial results for the third quarter of 2024, presenting notable shifts in revenue and product adoption. The company emphasizes its commitment to enhancing productivity through innovative...

Continue Reading
Sapiens Recognized for Outstanding Software Solutions Excellence

Updated Category News Views 220

Sapiens UnderwritingPro Achieves Recognition for Excellence Sapiens International Corporation has once again made waves in the insurance industry with its advanced UnderwritingPro solution. Renowned for driving efficiency and automation, the software provides comprehensive functionality that benefits insurers across various sectors. Honored with the XCelent Award...

Continue Reading
Opportunity for LAZR Investors: Join the Class Action Today

Updated Category News Views 175

Investing in Luminar Technologies: What You Need to Know For those invested in Luminar Technologies, Inc. (NASDAQ: LAZR), important news is unfolding regarding a recent class-action lawsuit that has potential implications for shareholders. The Rosen Law Firm, a reputable entity in securities law, has issued a reminder for investors who purchased Luminar securities during...

Continue Reading
Celebrating HVAC Techs: Behind-the-Scenes Heroes

Updated Category News Views 8

Recognizing the Unsung Heroes of Home Comfort Let's face it, HVAC techs don't always get the recognition they deserve. On National HVAC Technician Day, June 22, Bacon Plumbing Heating Air Electric took a moment to shine a light on those skilled folks keeping homes comfy year-round across the Dallas-Fort Worth Metroplex. You know, the folks who swoop in just in time during...

Continue Reading